These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
150 related articles for article (PubMed ID: 14705988)
21. HLA-B44 subtyping in a Spanish population: further evidence of Caucasian population diversity. Santos S; Vicario JL; Merino JL; Balas A Tissue Antigens; 1997 Feb; 49(2):124-8. PubMed ID: 9062967 [TBL] [Abstract][Full Text] [Related]
22. An HLA-B null allele (B*1526N) with a stop codon in exon 3 generated by a point mutation. Mine H; Ishikawa Y; Hojo M; Imashuku S; Tokunaga K; Juji T; Saji H; Yokoyama S Tissue Antigens; 1997 Oct; 50(4):351-4. PubMed ID: 9349618 [TBL] [Abstract][Full Text] [Related]
23. Identification of a new HLA-B*39 allele: HLA-B*3924. Cook JT; Day S; Dunn PP; Welsh KI; Bunce M Tissue Antigens; 2000 Aug; 56(2):178-9. PubMed ID: 11019922 [TBL] [Abstract][Full Text] [Related]
24. HLA-B44 subtyping in the Catalan population using reference strand mediated conformation analysis. Implications for the selection of unrelated bone marrow donors. Gallardo D; Aróstegui JI; Rodríguez-Luaces M; Querol S; González JR; García-López J; Grañena A Tissue Antigens; 2000 Aug; 56(2):173-7. PubMed ID: 11019921 [TBL] [Abstract][Full Text] [Related]
25. A Bw6-associated B44 allele (B*4409) identified by SSOP and corresponding serological results. Middleton D; Williams F; Curran MD; Martin J Tissue Antigens; 1997 Jun; 49(6):655-7. PubMed ID: 9234491 [No Abstract] [Full Text] [Related]
26. A nucleotide insertion in exon 4 is responsible for the absence of expression of an HLA-A*01 allele. Laforet M; Froelich N; Parissiadis A; Pfeiffer B; Schell A; Faller B; Woehl-Jaegle ML; Cazenave JP; Tongio MM Tissue Antigens; 1997 Oct; 50(4):347-50. PubMed ID: 9349617 [TBL] [Abstract][Full Text] [Related]
27. RNA processing and protein expression of HLA-B*07:44N. Balas A; García-Sánchez F; Vicario JL HLA; 2017 Apr; 89(4):230-234. PubMed ID: 28205408 [TBL] [Abstract][Full Text] [Related]
28. HLA-B44-directed cytotoxic T cells associated with acute graft-versus-host disease following unrelated bone marrow transplantation. Keever CA; Leong N; Cunningham I; Copelan EA; Avalos BR; Klein J; Kapoor N; Adams PW; Orosz CG; Tutschka PJ Bone Marrow Transplant; 1994 Jul; 14(1):137-45. PubMed ID: 7951101 [TBL] [Abstract][Full Text] [Related]
29. Long-range PCR amplification as an alternative strategy for characterizing novel HLA-B alleles. Curran MD; Williams F; Earle JA; Rima BK; van Dam MG; Bunce M; Middleton D Eur J Immunogenet; 1996 Aug; 23(4):297-309. PubMed ID: 8858286 [TBL] [Abstract][Full Text] [Related]
30. Complete cDNA sequence of B*4406, an HLA-B allele containing sequences of B*5101 and B*4402. Zhao W; Fernandez-Viña MA; Lazaro AM; Araujo HA; Miller S; Stastny P Tissue Antigens; 1996 May; 47(5):431-4. PubMed ID: 8795146 [No Abstract] [Full Text] [Related]
31. Involvement of the chaperone tapasin in HLA-B44 allelic losses in colorectal tumors. Cabrera CM; López-Nevot MA; Jiménez P; Garrido F Int J Cancer; 2005 Feb; 113(4):611-8. PubMed ID: 15455354 [TBL] [Abstract][Full Text] [Related]
33. HLA-A and HLA-B in Kenya, Africa: allele frequencies and identification of HLA-B*1567 and HLA-B*4426. Luo M; Embree J; Ramdahin S; Ndinya-Achola J; Njenga S; Bwayo JB; Pan S; Mao X; Cheang M; Stuart T; Brunham RC; Plummer FA Tissue Antigens; 2002 May; 59(5):370-80. PubMed ID: 12144620 [TBL] [Abstract][Full Text] [Related]
34. HLA class I (A, B) and II (DR, DQ) gene and haplotype frequencies in blood donors from Wales. Darke C; Guttridge MG; Thompson J; McNamara S; Street J; Thomas M Exp Clin Immunogenet; 1998; 15(2):69-83. PubMed ID: 9691201 [TBL] [Abstract][Full Text] [Related]
35. A novel HLA-B*40 allele and novel exon 1 sequences of two B*40 alleles identified in potential marrow donors. Gourley IS; Wu J; Bassinger S; Montoya GD; Yee J; Griffith BB; Kearns J; McKeen M; Birkos S; Williams TM; Kamoun M Tissue Antigens; 2000 Apr; 55(4):374-7. PubMed ID: 10852391 [TBL] [Abstract][Full Text] [Related]
36. A deletion in exon 3 results in a new HLA-A*01 null allele (A*0115N) in a Martinican woman. Béra O; Dubois V; Assaqa A; Belon P; Favre-Victoire I; Gebuhrer L Tissue Antigens; 2006 Jan; 67(1):61-3. PubMed ID: 16451203 [TBL] [Abstract][Full Text] [Related]
37. Mismatches outside exons 2 and 3 do not alter the peptide motif of the allele group B*44:02P. Bade-Doeding C; Cano P; Huyton T; Badrinath S; Eiz-Vesper B; Hiller O; Blasczyk R Hum Immunol; 2011 Nov; 72(11):1039-44. PubMed ID: 21872626 [TBL] [Abstract][Full Text] [Related]
38. Strong association between HLA-Cw*0706 and HLA-B*44032 in the Bubi population from Equatorial Guinea. van der Vlies SA; Voorter CE; de Pablo R; Vilches C; van den Berg-Loonen EM Tissue Antigens; 2000 Jan; 55(1):57-60. PubMed ID: 10703610 [TBL] [Abstract][Full Text] [Related]
39. A novel HLA-B*39 allele (HLA-B*3916) due to a rare mutation causing cryptic splice site activation. Tamouza R; El Kassar N; Schaeffer V; Carbonnelle E; Tatari Z; Marzais F; Fortier C; Poirier JC; Sadki K; Bernaudin F; Toubert A; Krishnamoorthy R; Charron D Hum Immunol; 2000 May; 61(5):467-73. PubMed ID: 10773349 [TBL] [Abstract][Full Text] [Related]
40. High frequency of HLA-B44 allelic losses in human solid tumors. Cabrera T; Maleno I; Lopez-Nevot MA; Redondo M; Fernandez MA; Collado A; Garrido F Hum Immunol; 2003 Oct; 64(10):941-50. PubMed ID: 14522091 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]